Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Calcium Pyrophosphate Deposition Disease Management

Treatment Approaches

  • The European League Against Rheumatism recommends comorbidity management, though the impact on CPPD outcomes remains unclear 1
  • Magnesium supplementation has shown symptom improvement but no reduction in radiographic calcification, according to the Annals of the Rheumatic Diseases 1
  • The treatment of associated conditions is required for early-onset disease, particularly hemochromatosis, as stated by the Annals of the Rheumatic Diseases 1

Research and Evidence

  • The Annals of the Rheumatic Diseases suggests that future research should focus on basic studies to better understand CPPD mechanisms and crystal effects on joint tissues 1
  • The evaluation of biological agents, particularly IL-1 inhibitors, for both acute and chronic CPP crystal arthritis is recommended by the Annals of the Rheumatic Diseases 1
  • Further investigation of methotrexate for chronic CPP inflammatory arthritis is needed, as stated by the Annals of the Rheumatic Diseases 1